1. Everolimus Plus Octreotide Long‐Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT‐2 Study. (21st December 2012) Authors: Castellano, Daniel; Bajetta, Emilio; Panneerselvam, Ashok; Saletan, Stephen; Kocha, Walter; O'Dorisio, Thomas; Anthony, Lowell B.; Hobday, Timothy Journal: Oncologist Issue: Volume 18:Number 1(2013) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancer. (April 2017) Authors: Vincent, Mark D; Breadner, Daniel; Soulieres, Denis; Kerr, Ian G; Sanatani, Michael; Kocha, Walter; Klimo, Peter; MacKenzie, Mary J; O'Connell, Anne; Whiston, Frances; Malpage, Anne S; Stitt, Larry; Welch, Stephen A Journal: Future oncology Issue: Volume 13:Number 9(2017) Page Start: 777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗